Blood glucose records
PreclinicalBiologic
Blood glucose records is one of 66 biologic programs targeting Metastasis. It is currently in Preclinical.
2
Indications
4
Total Trials
3
Active Trials
65
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
64 competitors in Metastasis
#DrugCompanyPhaseTrials
1Blenoxane
Bristol-Myers SquibbApproved
Gemzar
Johnson & JohnsonApproved
Norvir
AbbVieApproved
Neoral
NovartisApproved
Lynparza
AstraZenecaApproved
Tukysa
PfizerApproved
Taxol
TevaApproved
Trexall
Jazz PharmaceuticalsApproved
Femara
NovartisApproved
Camptosar
PfizerApproved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Colorectal Cancer2 trials
Eating Disorder1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Blood glucose records. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity Hospital, Montpellier